Amphastar P Stock Current Liabilities
| AMPH Stock | USD 42.68 0.22 0.52% |
Amphastar P fundamentals help investors to digest information that contributes to Amphastar's financial success or failures. It also enables traders to predict the movement of Amphastar Stock. The fundamental analysis module provides a way to measure Amphastar's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amphastar stock.
Amphastar |
Amphastar P Company Current Liabilities Analysis
Amphastar's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Amphastar Current Liabilities | 59.95 M |
Most of Amphastar's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amphastar P is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Amphastar P has a Current Liabilities of 59.95 M. This is 96.58% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 99.24% higher than that of the company.
Amphastar Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amphastar's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amphastar could also be used in its relative valuation, which is a method of valuing Amphastar by comparing valuation metrics of similar companies.Amphastar is currently under evaluation in current liabilities category among related companies.
Amphastar Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.21 % | ||||
| Operating Margin | 0.30 % | ||||
| Current Valuation | 2.41 B | ||||
| Shares Outstanding | 48.87 M | ||||
| Shares Owned By Insiders | 22.02 % | ||||
| Shares Owned By Institutions | 70.50 % | ||||
| Number Of Shares Shorted | 3.87 M | ||||
| Price To Earning | 972.67 X | ||||
| Price To Book | 2.98 X | ||||
| Price To Sales | 2.96 X | ||||
| Revenue | 644.39 M | ||||
| Gross Profit | 248.86 M | ||||
| EBITDA | 241.46 M | ||||
| Net Income | 137.54 M | ||||
| Cash And Equivalents | 183.39 M | ||||
| Cash Per Share | 3.74 X | ||||
| Total Debt | 623.64 M | ||||
| Debt To Equity | 0.21 % | ||||
| Current Ratio | 3.64 X | ||||
| Book Value Per Share | 13.30 X | ||||
| Cash Flow From Operations | 183.5 M | ||||
| Short Ratio | 10.56 X | ||||
| Earnings Per Share | 2.60 X | ||||
| Price To Earnings To Growth | 2.77 X | ||||
| Target Price | 63.25 | ||||
| Number Of Employees | 1.76 K | ||||
| Beta | 0.84 | ||||
| Market Capitalization | 2.07 B | ||||
| Total Asset | 1.51 B | ||||
| Retained Earnings | 409.27 M | ||||
| Working Capital | 264.19 M | ||||
| Current Asset | 175.93 M | ||||
| Current Liabilities | 59.95 M | ||||
| Net Asset | 1.51 B |
About Amphastar Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amphastar P's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amphastar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amphastar P based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amphastar in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amphastar's short interest history, or implied volatility extrapolated from Amphastar options trading.
Pair Trading with Amphastar
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amphastar position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amphastar will appreciate offsetting losses from the drop in the long position's value.Moving together with Amphastar Stock
| 0.63 | DVAX | Dynavax Technologies | PairCorr |
| 0.65 | VTRS | Viatris Financial Report 13th of May 2024 | PairCorr |
| 0.62 | EGRX | Eagle Pharmaceuticals | PairCorr |
Moving against Amphastar Stock
| 0.69 | FTLF | FitLife Brands Common | PairCorr |
| 0.67 | FLGC | Flora Growth Corp Financial Report 20th of May 2024 | PairCorr |
| 0.65 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
| 0.62 | HCM | HUTCHMED DRC | PairCorr |
| 0.55 | ACB | Aurora Cannabis Financial Report 12th of June 2024 | PairCorr |
The ability to find closely correlated positions to Amphastar could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amphastar when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amphastar - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amphastar P to buy it.
The correlation of Amphastar is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amphastar moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amphastar P moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amphastar can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Amphastar Piotroski F Score and Amphastar Altman Z Score analysis. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Amphastar Stock analysis
When running Amphastar's price analysis, check to measure Amphastar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amphastar is operating at the current time. Most of Amphastar's value examination focuses on studying past and present price action to predict the probability of Amphastar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amphastar's price. Additionally, you may evaluate how the addition of Amphastar to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Amphastar's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.